Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: Results of the neurocognitive substudy of the SALT randomized clinical trial

  1. Pérez-Valero, I.
  2. Pasquau, J.
  3. Rubio, R.
  4. Rivero, A.
  5. Santos, J.
  6. Sanz, J.
  7. Marino, A.
  8. Crespo, M.
  9. Hernández-Quero, J.
  10. Iribarren, J.A.
  11. Gutiérrez, F.
  12. Terrón, A.
  13. Esteban, H.
  14. Pérez-Molina, J.A.
Aldizkaria:
Journal of Antimicrobial Chemotherapy

ISSN: 1460-2091,  0305-7453

Argitalpen urtea: 2018

Alea: 73

Zenbakia: 9

Orrialdeak: 2444-2451

Mota: Artikulua

DOI: 10.1093/JAC/DKY212 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus